Royalties from Licenses

RF Financial Concepts 101 

Understanding the Business of the RF

Module 1: Understanding RF Sources of Income 

Funds Generated From Intellectual Property (IP) Commercialization

The RF provides innovation support services to the SUNY research community. These services help move technology and invention to the marketplace for public benefit.

Executing a license for a new technology or discovery is a key milestone in the intellectual property commercialization process and eventually yields one of the four primary sources of RF funds - royalty income.

What the Data Shows
Royalties from licenses is a source of RF funds, representing 1% of the total projected amount for 2016, for a total of $10.7 million.

Licensing of Inventions Drives Royalty Income

Xiaflex innovation medical

An example of an invention that yields royalty income is XIAFLEX®, the first non-surgical treatment of Dupuytren’s disease developed by researchers at Stony Brook University.

Following FDA approval in 2010, the drug has been administered to more than 40,000 patients in the United States and 46 Eurasian countries. It is approved in Canada and under review or to be submitted for review in other countries such as Japan, Australia, Mexico and Brazil.

Where to Find More Information 

Please refer to the 2016 Operating Plan